AiBST researcher, PhD student,Nyasha L. Mapira Shines at ASHG25: Recognized for Advancing Rare Genetic Disorders in Zimbabwe

AiBST proudly highlights a milestone on the global stage: Nyasha L. Mapira, a PhD student and AiBST researcher, presented her poster, “Advancing Rare Genetic Disorders (Mendelian Disorders) Screening and Diagnosis in Zimbabwe,” at the ASHG25 meeting in Boston, USA. Her work earned the Reviewer’s Choice Award, underscoring the rigor, relevance, and potential impact of research conducted within AiBST.

Nyasha’s experience at ASHG, supported by the ASHG Resource-limited Travel Award, exemplifies AiBST’s commitment to advancing genomics and precision medicine across Africa through international collaboration and mentorship.

Nyasha delivered a focused investigation into improving screening and diagnostic pathways for Mendelian (rare) disorders in Zimbabwe, with implications for early detection, treatment planning, and health equity. The ASHG25 meeting provided a premier global forum for researchers, clinicians, and advocates to share advances in human genetics and foster collaborative opportunities. “This being at ASHG has shown me the power of collaboration. I’ve learned from brilliant scientists and formed partnerships that will accelerate our path toward precision medicine in Africa.” — The work aims to strengthen diagnostic accuracy, inform policy discussions, and catalyze collaborations across institutions in Africa and beyond. By tailoring screening and diagnostic approaches to Zimbabwe’s context, the project supports scalable solutions that can be adapted elsewhere in the region.

Recognition, Quotes, and Implications

Nyasha received the Reviewer’s Choice Award, recognizing the study’s methodological rigor, relevance, and potential to improve patient care. This accolade highlights AiBST’s dedication to nurturing early-career scientists and elevating high-quality, globally relevant genetics research.

Nyasha’s reflections include:

“This recognition motivates us to push for innovative, equitable health outcomes for all. Our work in Zimbabwe is not just about diagnosing rare disorders—it’s about building a framework for access to accurate information, timely care, and hope for families who need it most.” — Mapira.

Mentorship and Support (attribution to mentors):

Special thanks to Prof. Collen Masimirembwa and Dr. Patience Kuona for their guidance and unwavering support, which are integral to AiBST’s mentorship ecosystem.

Why This Matters for Africa Zimbabwe’s evolving access to genetic screening benefits from practical, context-aware research like Nyasha’s, which can be scaled through partnerships. The work informs clinical practice, supports capacity-building, and strengthens local diagnostic capabilities. ASHG catalyzes international partnerships, capacity-building, and data sharing that accelerate progress in genomic health. AiBST’s mission is to advance health science and promote equitable care through innovative research and collaboration, strengthening Africa’s role in the global genomics landscape.

About AiBST and Nyasha’s Path

AiBST’s commitment is to support researchers at every stage—from study design to dissemination at high-profile forums—driven by mentorship and collaborative networks. Nyasha’s path illustrates how AiBST nurtures impactful science that resonates beyond borders and drives real-world health improvements. Future directions include continued work in Mendelian disorders, expanded diagnostic frameworks, and strengthened regional and international partnerships.

As AiBST continues to advance genomics and precision medicine in Africa, Nyasha’s work embodies the impact of mentorship, collaboration, and resilient research ecosystems.